Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment
NCT01632436
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
No eligible patients enrolled
Conditions
Metastatic Cancer
Interventions
DRUG:
Pixantrone
Sponsor
CTI BioPharma